Study Details

Back to Search Results

A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT01565655

Astellas Study ID

The unique identification code given by the study sponsor.

015K-CL-RA22

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

2011-006020-20

Follow Trial

Condition

Rheumatoid Arthritis

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

18 years - N/A

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Jun 2012 - Dec 2013

Masking

Triple (Participant, Care Provider, Outcomes Assessor)

Enrollment number

289

A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Patients

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Rethy Pal Korhaz es Rendelointezet

Bekescsaba, Hungary, 5600

Achieve Clinical Research, LLC

Birmingham, United States, 35216

Health Research of Oklahoma

Oklahoma City, United States, 73103

Cliditer S.A. de C.V.

México, Mexico, 6700

Budai Irgalmasrendi Korhaz

Budapest,, Hungary, 1027

NZOZ Centrum Medyczne ProMiMed

Krakow, Poland, 31-637

MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o.

Uherske Hradiste, Czech Republic, 68601

MHAT "Sv. Ivan Rilski"

Sofia, Bulgaria, 1612

Arthritis Associates

Orlando, United States, 32804

Jacksonville Center for Clinical Research

Jacksonville, United States, 32216

Pacific Arthritis Center Medical Group

Santa Maria, United States, 93454

Stanford University School of Medicine

Palo Alto, United States, 94304

Desert Medical Advances

Palm Desert, United States, 92260

Orszgos Reumatolgiai s Fizioterpis Intzet

Budapest, Hungary, 1027

Kenezy Hospital Institute of Clinical Pharmacology

Debrecen, Hungary, H-4043

Clincal Research Center of Reading

Wyomissing, United States, 19610

PV-MEDICAL s.r.o.

Zlin, Czech Republic, 760 01

Zespol Poradni Specjalistycznych, REUMED sp. Zo.o

Lublin, Poland, 20-582

The Center for Rheumatology and Bone Research

Wheaton, United States, 20902

PMG Research

Hickory, United States, 28602

Center for Arthritis and Osteoporosis

Elizabethtown, United States, 42701

Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela

Bydgoszcz, Poland, 85-168

Mountain State Clinical Research

Clarksburg, United States, 26301

Altoona Center for Clinical Research

Duncansville, United States, 16635

Revita Clinic Rheumatology

Budapest, Hungary, 1027

Centro de Investigacion Clinica de Morelia, S.C.

Morelia, Mexico, 58070

Revmatologicky ustav

Praha 2, Czech Republic, 128 50

University of California San Diego

LaJolla, United States, 92093-0943

ARS Rheumatica

Warszawa, Poland, 02-653

MHAT Plovdiv AD

Plovdiv, Bulgaria, 4003

Revmatologicka ambulance

Praha-Nusle, Czech Republic, 140 00

Deerbrook Medical Asssociates

Vernon Hills, United States, 60061

Arthritis Associates of Colorado Springs

Colorado Springs, United States, 80910

Dr Javier Orozco Alcala Private Doctor´s office

Guadalajara, Mexico, 44650

Rheumatology Consultants, PLLC

Knoxville, United States, 37909-1907

Austin Rheumatology Research PA

Austin, United States, 78705

Illinois Bone & Joint Institute; LLC

Morton Grove, United States, 60053

MHAT Burgas

Burgas, Bulgaria, 8000

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo